•
Apr 01, 2023

Thermo Fisher Q1 2023 Earnings Report

Thermo Fisher Scientific's financial performance remained strong in Q1 2023, marked by strategic advancements and innovation.

Key Takeaways

Thermo Fisher Scientific reported a revenue of $10.71 billion, a 9% decrease compared to the same quarter last year. Core organic revenue growth was 6%. GAAP EPS was $3.32, and adjusted EPS was $5.03. The company launched innovative products, strengthened partnerships, and progressed towards renewable energy goals.

Revenue reached $10.71 billion, reflecting a 9% decrease year-over-year, with a core organic revenue growth of 6%.

GAAP diluted earnings per share (EPS) was reported at $3.32.

Adjusted EPS stood at $5.03.

The company actively deployed capital, including $3.0 billion in stock repurchases and a 17% dividend increase.

Total Revenue
$10.7B
Previous year: $11.8B
-9.4%
EPS
$5.03
Previous year: $7.25
-30.6%
Organic Revenue Growth
-8%
Previous year: 3%
-366.7%
Adjusted Operating Margin
21.8%
Gross Profit
$4.27B
Previous year: $5.6B
-23.8%
Cash and Equivalents
$3.48B
Previous year: $2.75B
+26.5%
Free Cash Flow
$277M
Previous year: $1.56B
-82.3%
Total Assets
$94.7B
Previous year: $92.7B
+2.1%

Thermo Fisher

Thermo Fisher

Thermo Fisher Revenue by Segment

Forward Guidance

The company will provide updates on its 2023 financial guidance during its earnings conference call this morning at 8:30 a.m. Eastern time.

Revenue & Expenses

Visualization of income flow from segment revenue to net income